Topical Collection on Management of the Cirrhotic Patient

ISSN: 2195-9595 (Online)

In this topical collection (24 articles)

previous Page of 2
  1. No Access

    Management of the Cirrhotic Patient (A Cardenas and N Reau, Section Editors)

    Statins: the Panacea of Cirrhosis?

    Lourdes Cabrera, Juan G. Abraldes Pages 1-7
  2. No Access

    Management of the Cirrhotic Patient (NS Reau and A Cardenas, Section Editors)

    Portal Vein Thrombosis in Patients with Cirrhosis—Etiology, Diagnosis, and Management

    Nicolas M. Intagliata, Zachary H. Henry, Patrick G. Northup Pages 1-8
  3. No Access

    Management of the Cirrhotic Patient (A Cardenas and N Reau, Section Editors)

    Portopulmonary Hypertension and Hepatopulmonary Syndrome: Is Transplant Always the Answer?

    Gurneet Bedi, Karen L. Krok Pages 8-16
  4. No Access

    Management of the Cirrhotic Patient (NS Reau and A Cardenas, Section Editors)

    Assessment of Bleeding Risk in Patients with Cirrhosis

    Alberto Zanetto, Marco Senzolo, Alberto Ferrarese Pages 9-18
  5. No Access

    Management of the Cirrhotic Patient (NS Reau and A Cardenas, Section Editors)

    HCC: Where Does HCV Therapy Play a Role?

    Stacey Prenner, Laura Kulik Pages 17-25
  6. No Access

    Management of the Cirrhotic Patient (NS Reau and A Cardenas, Section Editors)

    Covert Hepatic Encephalopathy: How Aggressive Should We Be with Diagnosis and Management?

    Sanath Allampati, Suleiman Abdal Raheem, Kevin D. Mullen Pages 19-24
  7. No Access

    Management of the Cirrhotic Patient (NS Reau and A Cardenas, Section Editors)

    Non-cirrhotic Hyperammonemia—When High Ammonia Is not Always from Cirrhosis

    Sumit Kumar, Sumeet K. Asrani Pages 25-31
  8. No Access

    Management of the Cirrhotic Patient (A Cardenas and N Reau, Section Editors)

    Acute Kidney Injury in the Cirrhotic Patient: Unique Features and Challenges

    Rakhi Maiwall, Richard Moreau Pages 26-35
  9. No Access

    Management of the Cirrhotic Patient (NS Reau and A Cardenas, Section Editors)

    Sustained Virological Response and Hepatitis C-Related Cirrhosis: a World of Opportunities

    Maria-Carlota Londoño, Javier Hernández-Blanco Pages 32-39
  10. No Access

    Management of the Cirrhotic Patient (NS Reau and A Cardenas, Section Editors)

    Acute-on-Chronic Liver Failure: Can We Agree on a Definition?

    Douglas A. Simonetto, Patrick S. Kamath Pages 40-45
  11. No Access

    Management of the Cirrhotic Patient (A Cardenas and N Reau, Section Editors)

    Does SVR Prevent Transplant in HCV?

    Whitney E. Jackson, Elizabeth C. Verna Pages 44-52
  12. No Access

    Management of the Cirrhotic Patient (NS Reau and A Cardenas, Section Editors)

    The Use of Beta-Blockers in Advanced Cirrhosis—Where Do We Stand?

    Juan G. Abraldes, Puneeta Tandon Pages 46-52
  13. No Access

    Management of the Cirrhotic Patient (NS Reau and A Cardenas, Section Editors)

    The Management of Hyponatremia in Cirrhosis: Should it Be Pharmacologic?

    Elsa Solà, Patricia Huelin, Pere Ginès Pages 53-59
  14. No Access

    Management of the Cirrhotic Patient (NS Reau and A Cardenas, Section Editors)

    Critical Care Management in Cirrhosis

    Sunil Dacha, Ram M. Subramanian Pages 60-68
  15. Management of the Cirrhotic Patient (A Cardenas and N Reau, Section Editors)

    Alcohol Consumption in Concomitant Liver Disease: How Much is Too Much?

    Hannes Hagström Pages 152-157
  16. No Access

    Management of the Cirrhotic Patient (A Cardenas and N Reau, Section Editors)

    Portal Vein Thrombosis and Cirrhosis: The Role of Anticoagulation

    Andrea Mancuso Pages 158-163
  17. No Access

    Management of the Cirrhotic Patient (A Cardenas and N Reau, Section Editors)

    Biomarkers and Liver Disease: Can We Predict Decompensation with suPAR?

    Alexander Koch, Frank Tacke Pages 164-168
previous Page of 2